INR 88.75
(2.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 48.82 Million | 12.59 Million | 18.65 Million | 30.37 Million | 53.5 Million |
Cost of Revenue | 22.38 Million | 7.82 Million | 6.36 Million | 17.99 Million | 34.42 Million |
Gross Profit | 26.44 Million | 4.76 Million | 12.29 Million | 12.37 Million | 19.07 Million |
Operating Expenses | 5.7 Million | 2.87 Million | 2.36 Million | 4.9 Million | 4.57 Million |
Selling, General and Administrative Expenses | - | 656.34 Thousand | 454.24 Thousand | 1.02 Million | 1.31 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 5.7 Million | 39.33 Thousand | 7510.00 | 155.97 Thousand | 222.24 Thousand |
Cost and Expenses | 28.08 Million | 10.7 Million | 8.72 Million | 22.89 Million | 39 Million |
Operating Income | 20.74 Million | 6.59 Million | 14.64 Million | 21 Million | 32.3 Million |
Interest Expense | 5.83 Million | 90.92 Thousand | 1930.00 | 3.28 Million | 6.7 Million |
Income Tax Expense | 6.84 Million | 5.33 Million | 4.44 Million | 1.3 Million | 6.72 Million |
Earnings before Tax | 29.95 Million | 15.1 Million | 18.1 Million | -2.27 Million | 25.92 Million |
Net Income | 23.11 Million | 9.77 Million | 13.66 Million | -3.57 Million | 19.2 Million |
Earnings Per Share Basic | 3.66 | 1.56 | 2.19 | -0.57 | 3.07 |
Earnings Per Share Diluted | 3.66 | 1.56 | 2.19 | -0.57 | 3.07 |
Weighted Average Shares Outstanding | 6.31 Million | 6.25 Million | 6.25 Million | 6.25 Million | 6.25 Million |
Weighted Average Shares Outstanding (Diluted) | 6.31 Million | 6.25 Million | 6.25 Million | 6.25 Million | 6.25 Million |
Gross Margin | 0.54 | 0.38 | 0.66 | 0.41 | 0.36 |
EBIT Margin | 0.74 | 0.54 | 0.79 | 0.70 | 0.61 |
Profit Margin | 0.47 | 0.78 | 0.73 | -0.12 | 0.36 |
EBITDA | 36.07 Million | 15.4 Million | 18.29 Million | 21.18 Million | 32.86 Million |
Earnings Before Tax Margin | 0.42 | 0.52 | 0.78 | 0.69 | 0.60 |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | 20.92 Million | 48.82 Million | 6.59 Million | 16.9 Million | 4.4 Million | 12.59 Million |
Cost of Revenue | 14.33 Million | 22.38 Million | 2.77 Million | 2.92 Million | 2.34 Million | 7.82 Million |
Gross Profit | 6.58 Million | 26.44 Million | 3.81 Million | 13.98 Million | 2.06 Million | 4.76 Million |
Operating Expenses | 2.48 Million | 5.7 Million | 1.2 Million | 927 Thousand | 1.08 Million | 2.87 Million |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 2.99 Million | 15.04 Million | 2.31 Million | 2.9 Million | 6.83 Million | 39.33 Thousand |
Cost and Expenses | 16.81 Million | 28.08 Million | 3.98 Million | 3.85 Million | 3.43 Million | 10.7 Million |
Operating Income | 7.09 Million | 35.78 Million | 4.92 Million | 15.96 Million | 7.8 Million | 6.59 Million |
Interest Expense | 1.18 Million | 5.83 Million | 1.31 Million | 2.08 Million | 1.24 Million | 90.92 Thousand |
Income Tax Expense | 741 Thousand | 6.84 Million | 951 Thousand | 3.55 Million | 1.6 Million | 5.33 Million |
Earnings before Tax | 5.91 Million | 29.95 Million | 3.6 Million | 13.87 Million | 6.56 Million | 15.1 Million |
Net Income | 5.17 Million | 23.11 Million | 2.65 Million | 10.32 Million | 4.96 Million | 9.77 Million |
Earnings Per Share Basic | 0.82 | - | 0.42 | 1.65 | 0.79 | - |
Earnings Per Share Diluted | 0.82 | - | 0.42 | 1.65 | 0.79 | - |
Weighted Average Shares Outstanding | 6.31 Million | 6.31 Million | 6.31 Million | 6.25 Million | 6.27 Million | 6.25 Million |
Weighted Average Shares Outstanding (Diluted) | 6.31 Million | 6.31 Million | 6.31 Million | 6.25 Million | 6.27 Million | 6.25 Million |
Gross Margin | 0.31 | 0.54 | 0.58 | 0.83 | 0.47 | 0.38 |
EBIT Margin | 0.34 | - | 0.76 | 0.95 | 1.79 | - |
Profit Margin | 0.25 | 0.47 | 0.40 | 0.61 | 1.13 | 0.78 |
EBITDA | 7.15 Million | - | 4.99 Million | 16.04 Million | 7.87 Million | - |
Earnings Before Tax Margin | 0.34 | 0.73 | 0.75 | 0.94 | 1.77 | 0.52 |
SHIVAGR
HAR
PAT
3611
PGM
AAREYDRUGS